ViaDerma, Inc. (VDRM)
OTCMKTS · Delayed Price · Currency is USD
0.0003
+0.0002 (200.00%)
Sep 12, 2025, 10:05 AM EDT
ViaDerma Market Cap
ViaDerma has a market cap or net worth of $370.11 thousand as of September 12, 2025. Its market cap has decreased by -94.17% in one year.
Market Cap
370.11K
Enterprise Value
n/a
Revenue
44.69K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since August 6, 2009, ViaDerma's market cap has decreased from 30.60M to 370.11K, a decrease of -98.79%. That is a compound annual growth rate of -23.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 370.11K | -95.95% |
| Dec 31, 2024 | 9.13M | -30.19% |
| Dec 29, 2023 | 13.08M | 114.62% |
| Dec 30, 2022 | 6.09M | -28.79% |
| Dec 31, 2021 | 8.56M | 452.93% |
| Dec 31, 2020 | 1.55M | 44.98% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 789.71M |
| Elite Pharmaceuticals | 750.21M |
| Tian'an Technology Group | 723.74M |
| Glass House Brands | 566.73M |
| Northwest Biotherapeutics | 390.10M |
| CytoDyn | 358.38M |
| American Oncology Network | 353.52M |